Research demonstrates that AOD-9604 upregulates beta-3 adrenergic receptors in fat cells, promoting energy expenditure and fat oxidation through mechanisms distinct from traditional stimulants or full growth hormone
fluid in lungs or heart issues
Pair a Vitamin D3 injection with any of our IV Infusions for a healthy boost
Inform your doctor if you are pregnant, planning to become pregnant, or breastfeeding
Neurological Protection Long-term B12 deficiency causes progressive neurological damage, including peripheral neuropathy, memory loss, and in severe cases, subacute combined degeneration of the spinal cord
Main human AOD-9604 treatment timelines Study METAOD004 Participants 36 Route Oral Treatment length 7 days Dose range 9, 27, or 54 mg/day Main lesson Short safety and tolerability study Study METAOD005 Participants 300 Route Oral Treatment length 12 weeks Dose range 1 to 30 mg/day Main lesson Earlier weight-loss trial with a non-linear dose response Study METAOD006 Participants 502 randomized Route Oral Treatment length 24 weeks Dose range 0.25, 0.5, or 1 mg/day Main lesson Primary weight-loss goal was not met The oral milligram doses in these trials cannot be converted into subcutaneous microgram doses